MindWalk Holdings Corp. (HYFT)

MindWalk Holdings Corp. is a biotechnology company that combines artificial intelligence with laboratory capabilities to discover and develop antibody and other biologic therapeutics. The company was formerly known as ImmunoPrecise Antibodies Ltd. before adopting its current name.

Its computational platform, known as LENSai, analyzes biological sequence and structural data to identify drug targets and design therapeutic candidates, while its laboratory operations provide antibody discovery and related services to pharmaceutical and biotechnology customers. The company also pursues its own pipeline programs built on these technologies.

Its common stock trades on the Nasdaq under the ticker HYFT.